xamoterol has been researched along with Coronary Disease in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (68.00) | 18.7374 |
| 1990's | 8 (32.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pouleur, H; Rousseau, MF; Vincent, MF | 1 |
| Brasseur, LA; Buy, JJ; Decoster, PM; Detry, JM; Rousseau, MF | 1 |
| Cheron, P; Etienne, J; Mengeot, P; Pouleur, H; Rousseau, MF | 1 |
| Ikäheimo, MJ; Takkunen, JT | 1 |
| Katayama, K; Kohno, M; Kumada, T; Kusukawa, R; Matsuzaki, M; Miura, T; Ozaki, M; Toma, Y; Yonezawa, F | 1 |
| Bleifeld, W; Erlemeier, HH; Kupper, W | 2 |
| Etienne, J; Gurné, O; Pouleur, H; Rousseau, MF; Van Mechelen, H | 1 |
| de Feyter, PJ; Serruys, PW | 1 |
| Simonsen, S | 1 |
| Hanet, C; Pouleur, H; Rousseau, MF; van Eyll, C | 1 |
| Hine, FL; Marlow, HF; Pouleur, H; Rousseau, MF; Snow, HM | 1 |
| Marlow, HF | 1 |
| Charlier, AA; Debaisieux, JC; Pouleur, H; Rousseau, MF; Van Eyll, C | 1 |
| Böhm, M; Erdmann, E; Mittmann, C; Schwinger, R | 1 |
| Etienne, J; Pouleur, H; Rousseau, MF; van Eyll, C; van Mechelen, H; Vuylsteke, A | 1 |
| Faergeman, O; Snow, HM; Vigholt-Sørensen, E | 1 |
| Bhalla, KK; Sykes, CA; Waller, DG; Webster, J; Wray, R | 1 |
| Charlier, AA; Hanet, C; Marlow, HF; Pouleur, H; Rousseau, MF | 1 |
| Bennett, DH; Molajo, AO | 1 |
| Cheron, P; Lavenne, F; Nannan, M; Pouleur, H; Rousseau, MF; Vincent, MF | 1 |
| Bowes, RJ; Gautam, PC; Graham, DR; Harley, A | 1 |
| Abiko, Y; Hino, T; Sakai, K; Sashida, H | 1 |
| Bastain, W; Bennett, DH; Marlow, HF; Molajo, AO; Snow, HM | 1 |
| Charlier, AA; Cheron, P; Hanet, C; Pouleur, H; Rousseau, MF; van Eyll, C | 1 |
1 review(s) available for xamoterol and Coronary Disease
| Article | Year |
|---|---|
The efficacy of xamoterol in heart failure of ischemic origin.
Topics: Adrenergic beta-Agonists; Coronary Disease; Heart Failure; Humans; Propanolamines; Xamoterol | 1989 |
7 trial(s) available for xamoterol and Coronary Disease
| Article | Year |
|---|---|
Exercise capacity, arrhythmias, humoral and chemical parameters during long-term therapy with xamoterol.
Topics: Adrenergic beta-Agonists; Cardiac Complexes, Premature; Coronary Disease; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Random Allocation; Renin; Time Factors; Xamoterol | 1990 |
[Hemodynamic and humoral changes following intravenous administration of xamoterol in patients with heart failure and coronary heart disease].
Topics: Adrenergic beta-Agonists; Adult; Cardiac Output; Clinical Trials as Topic; Coronary Disease; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Norepinephrine; Propanolamines; Renin; Xamoterol | 1990 |
Acute haemodynamic effects of the beta 1-adrenoceptor partial agonist xamoterol at rest and during supine exercise in patients with left ventricular dysfunction due to ischaemic heart disease: a double-blind randomized trial.
Topics: Adrenergic beta-Agonists; Adult; Aged; Blood Pressure; Cardiac Output; Coronary Disease; Double-Blind Method; Exercise; Humans; Male; Middle Aged; Propanolamines; Randomized Controlled Trials as Topic; Xamoterol | 1990 |
Effects of xamoterol, a beta 1 adrenoceptor partial agonist, in patients with ischaemic dysfunction of the left ventricle.
Topics: Adrenergic beta-Agonists; Adult; Aged; Cardiac Output, Low; Coronary Disease; Double-Blind Method; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Propanolamines; Randomized Controlled Trials as Topic; Xamoterol | 1989 |
Clinical efficacy of xamoterol, a beta 1-adrenoceptor partial agonist, in mild to moderate heart failure. U.K. Xamoterol Study Group.
Topics: Adrenergic beta-Agonists; Adult; Aged; Angina Pectoris; Coronary Disease; Double-Blind Method; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Multicenter Studies as Topic; Propanolamines; Quality of Life; Randomized Controlled Trials as Topic; Single-Blind Method; Xamoterol | 1989 |
The effects and dose-response relationship of xamoterol in patients with ischaemic heart disease.
Topics: Adrenergic beta-Agonists; Adult; Coronary Disease; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Male; Middle Aged; Physical Exertion; Propanolamines; Xamoterol | 1987 |
Long-term effects of xamoterol on left ventricular diastolic function and late remodeling: a study in patients with anterior myocardial infarction and single-vessel disease.
Topics: Adrenergic beta-Agonists; Cardiac Catheterization; Cardiomegaly; Clinical Trials as Topic; Coronary Disease; Diastole; Female; Heart; Heart Ventricles; Hemodynamics; Humans; Male; Myocardial Contraction; Myocardial Infarction; Propanolamines; Radiography; Time Factors; Xamoterol | 1988 |
17 other study(ies) available for xamoterol and Coronary Disease
| Article | Year |
|---|---|
Effects of a cardioselective beta 1 partial agonist (corwin) on left ventricular function and myocardial metabolism in patients with previous myocardial infarction.
Topics: Adrenergic beta-Agonists; Adult; Coronary Disease; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardium; Propanolamines; Stroke Volume; Xamoterol | 1983 |
Antianginal effects of corwin, a new beta-adrenoceptor partial agonist.
Topics: Adrenergic beta-Agonists; Angina Pectoris; Cardiac Output; Coronary Disease; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Physical Exertion; Propanolamines; Pulmonary Wedge Pressure; Stimulation, Chemical; Xamoterol | 1984 |
[Effects of a partial agonist of beta 1 adrenergic receptors (ICI 118,587) on left ventricular performance and metabolism in coronary disease].
Topics: Adrenergic beta-Agonists; Adult; Coronary Angiography; Coronary Disease; Female; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Propanolamines; Xamoterol | 1984 |
The effects of beta 1-adrenoceptor partial agonist ICI 118.587 on left ventricular function in patients with coronary heart disease.
Topics: Adult; Angina Pectoris; Coronary Disease; Echocardiography; Electrocardiography; Female; Heart; Hemodynamics; Humans; Male; Middle Aged; Propanolamines; Stimulation, Chemical; Xamoterol | 1984 |
Effects of the partial beta 1-adrenergic agonist, xamoterol, on hemodynamics and regional myocardial function during acute coronary occlusion in dogs.
Topics: Acute Disease; Adrenergic beta-Antagonists; Anesthesia; Animals; Coronary Disease; Dogs; Heart; Hemodynamics; Isoproterenol; Myocardial Contraction; Propanolamines; Xamoterol | 1990 |
Effects of the beta 1-adrenergic receptor partial agonist xamoterol on left ventricular diastolic function. An evaluation after 1-6 years of oral therapy.
Topics: Administration, Oral; Adrenergic beta-Agonists; Coronary Disease; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Propanolamines; Time Factors; Xamoterol | 1990 |
The effects of xamoterol and pacing on myocardial blood flow and metabolism in patients with coronary artery disease.
Topics: Adrenergic beta-Agonists; Coronary Circulation; Coronary Disease; Humans; Male; Middle Aged; Myocardium; Propanolamines; Xamoterol | 1990 |
Relation of diastolic function and exercise capacity in ischemic left ventricular dysfunction. Role of beta-agonists and beta-antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Coronary Disease; Diastole; Exercise; Exercise Test; Female; Heart; Heart Ventricles; Humans; Male; Middle Aged; Physical Endurance; Propanolamines; Rest; Time Factors; Xamoterol | 1990 |
Relationship between positive inotropic responses and plasma concentrations of xamoterol in middle-aged and elderly patients.
Topics: Adult; Aged; Aging; Coronary Disease; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Myocardial Contraction; Propanolamines; Substance Withdrawal Syndrome; Xamoterol | 1990 |
Contrasting effects of single doses of pindolol and xamoterol on left ventricular diastolic function.
Topics: Adrenergic beta-Agonists; Blood Pressure; Coronary Disease; Diastole; Female; Heart; Heart Rate; Humans; Male; Pindolol; Propanolamines; Xamoterol | 1989 |
Xamoterol and the failing heart.
Topics: Adrenergic beta-Agonists; Coronary Disease; Humans; Myocardial Contraction; Propanolamines; Xamoterol | 1989 |
Effects of long-term xamoterol therapy on the left ventricular mechanical efficiency in patients with ischemic heart disease.
Topics: Adrenergic beta-Agonists; Coronary Disease; Heart; Humans; Propanolamines; Xamoterol | 1989 |
Left ventricular sensitivity to beta-adrenoceptor-stimulating drugs in patients with ischemic heart disease and varying degrees of ventricular dysfunction.
Topics: Aged; Coronary Disease; Dose-Response Relationship, Drug; Female; Heart; Heart Diseases; Heart Ventricles; Humans; Isoproterenol; Male; Middle Aged; Propanolamines; Receptors, Adrenergic, beta; Sympathomimetics; Xamoterol | 1987 |
Effect of xamoterol (ICI 118587), a new beta1 adrenoceptor partial agonist, on resting haemodynamic variables and exercise tolerance in patients with left ventricular dysfunction.
Topics: Adrenergic beta-Agonists; Cardiac Output; Coronary Disease; Dyspnea; Female; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Physical Exertion; Propanolamines; Pulmonary Wedge Pressure; Stroke Volume; Vascular Resistance; Xamoterol | 1985 |
[Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)].
Topics: Administration, Oral; Adrenergic beta-Agonists; Adult; Coronary Disease; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Propanolamines; Tachyphylaxis; Time Factors; Xamoterol | 1985 |
The electrophysiological effects of intravenous xamoterol in man.
Topics: Adrenergic beta-Agonists; Adult; Blood Pressure; Coronary Disease; Electrocardiography; Heart Conduction System; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Propanolamines; Xamoterol | 1986 |
Effect of xamoterol, a beta 1-adrenoceptor partial agonist, on myocardial pH decreased by coronary occlusion in dogs.
Topics: Adrenergic beta-Agonists; Animals; Coronary Circulation; Coronary Disease; Dogs; Dose-Response Relationship, Drug; Female; Hemodynamics; Hydrogen-Ion Concentration; Male; Myocardium; Propanolamines; Xamoterol | 1986 |